大北農(002385.SZ):7月銷售收入環比增19.73%、同比降23.88%
格隆匯8月3日丨大北農(002385.SZ)公佈2022年7月份生豬銷售情況簡報,公司控股及參股公司銷售情況如下:
2022年7月銷售生豬27.03萬頭,銷售收入6.31億元。其中銷售收入環比增長19.73%,同比增長-23.88%;銷售數量環比增長-5.42%,同比增長-41.26%;商品肥豬出欄均重120.69公斤,銷售均價21.5元/公斤。
2022年1-7月,累計銷售生豬225.35萬頭,同比增長6.12%。累計銷售收入35.56億元,同比增長-33.35%。
2022年7月銷售數量同比降低主要是因為受前期淘汰低效能母豬從而投苗減少所致。
2022年1-7月累計銷售收入同比降低主要受上半年國內生豬市場行情變化所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.